NCT03208972

Elonva in Combination With Hp-FSH Versus Elonva With Low Dose hCG

Prospective Randomized Trial Comparing Ovarian Stimulation in IVF-patients With Corifollitropin Alfa in Combination With Hp-FSH Versus Corifollitropin Alfa in Combination With Low Dose hCG

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 107 (actual)
• Sponsor: AZ Jan Palfijn Gent · Academic / Other
• Sex: Female
• Age: 18 Years – 38 Years
• Healthy volunteers: Accepted

Summary

The study compares in a randomized controlled way two stimulation methods. One of these stimulation methods implements a new insight in ovarian follicular growth. If this novel method of stimulation proves to be as efficient as the classical stimulation protocols, there might be a dramatic reduction of the costs of the medical therapy in IVF, thus reducing also the overall IVf costs significantly.

Conditions

• Infertility

Interventions

Type	Name	Description
DRUG	low dose hCG
DRUG	hp-FSH
DRUG	Corifollitropin Alfa	Corifollitropin Alfa (Elonva) dosage depending on weight, once administered first day of ovarian stimulation for all subjects, and on day 7 they proceed with the treatment of the allocated group. \<60 kg: Elonva 100 MCG \> 60 kg: Elonva 150 MCG

Timeline

• Start date: 2014-10-01
• Primary completion: 2015-11-01
• Completion: 2015-11-01
• First posted: 2017-07-06
• Last updated: 2021-02-03

Locations

1 site across 1 country: Belgium